These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Overcoming weaknesses in therapy. Protease inhibitors with high IQ]. MMW Fortschr Med; 2001 Apr; 143 Suppl 1():96-7. PubMed ID: 11373795 [No Abstract] [Full Text] [Related]
3. [No resistance even after 1 year. New drug combination against HIV]. MMW Fortschr Med; 2001 Apr; 143 Suppl 1():108. PubMed ID: 11373766 [No Abstract] [Full Text] [Related]
4. [HIV therapy in childhood. Also once daily lopinavir/r is effective]. MMW Fortschr Med; 2005 Apr; 147 Spec No 1():55. PubMed ID: 16385877 [No Abstract] [Full Text] [Related]
5. [Simplified HIV therapy. Atazanavir: the first protease inhibitor with once daily administration]. MMW Fortschr Med; 2004 Apr; 146 Spec No 1():14-6. PubMed ID: 15373035 [No Abstract] [Full Text] [Related]
6. [New data on atazanavir/r]]. MMW Fortschr Med; 2005 Apr; 147 Spec No 1():81-3. PubMed ID: 16385887 [No Abstract] [Full Text] [Related]
7. [First-line monotherapy with boostered protease inhibitor. Effectively reduce viral load with only one drug?]. Theobald T; Jäger H MMW Fortschr Med; 2005 Apr; 147 Spec No 1():28-9. PubMed ID: 16385867 [No Abstract] [Full Text] [Related]